A Research Guide for
Charcot-Marie-Tooth

Understanding Charcot-Marie-Tooth disease — the types, diagnosis, the supportive care that maintains mobility (therapy, braces, foot care), the vital safety point about avoiding nerve-toxic medicines, the first CMT1A treatments in trials, and inheritance — organized by where you are in the journey.

This guide is not medical advice. It is an educational research summary written in plain language, drawn from published medical literature, major clinical trials, and official guidelines. Every important decision must be made together with the patient’s medical team. Nothing here replaces those conversations. The purpose of this guide is to help patients and families walk into those conversations better prepared. This content does not create a doctor-patient relationship. Trouvera’s guides are produced using AI-assisted research synthesis with human editorial review; they are not written by treating physicians. Laws regarding medical information vary by jurisdiction; consult a local licensed professional for advice specific to your situation.
Standard care first. Every option in this guide is intended as an addition to, not a replacement for, evidence-based care delivered by a qualified multidisciplinary team. The foundation of CMT care is confirming the diagnosis (and ideally the genetic type), lifelong supportive management (physical and occupational therapy, ankle-foot orthoses and footwear, foot care, exercise, pain control, and fall prevention), strict avoidance of nerve-toxic medicines (above all vincristine), genetic counseling tailored to the subtype, and — for now — supportive rather than disease-modifying therapy, with the first CMT1A-targeted treatment still investigational.
Safety warning. Certain medicines can severely and sometimes permanently worsen Charcot-Marie-Tooth disease — above all the chemotherapy drug vincristine, which must be avoided. Always tell every doctor, including oncologists, surgeons, and anesthesiologists, that you have CMT, and ask whether any prescribed medicine could affect the nerves. Also seek care for new foot wounds (which may not be felt), worsening balance or falls, or any unusually rapid change in symptoms, which can signal a separate, treatable problem.
Content last reviewed: June 2026  ·  Based on Drawn from neuromuscular references on CMT classification and genetics, supportive-management consensus, the Charcot-Marie-Tooth Association neurotoxic-medication guidance, and the CMT1A trials of PXT3003 (PLEO-CMT, PREMIER), plus ClinicalTrials.gov registry data.  ·  Always verify with your medical team.

⚡ Quick Start — If You Read Nothing Else

The 10 most important things to know about Charcot-Marie-Tooth disease.

  1. CMT is the most common inherited nerve disorder — it affects the peripheral nerves (those outside the brain and spinal cord), causing slowly progressive weakness and numbness, usually starting in the feet and lower legs and later the hands.
  2. It is not life-threatening and does not affect the brain or thinking. CMT affects movement and sensation; most people have a normal lifespan and stay active, though it can affect mobility, balance, and dexterity over time.
  3. There are many genetic types. The most common is CMT1A (a duplication of the PMP22 gene); others include CMT2 (axonal types), CMTX (X-linked), and more. Knowing your type helps guide care and family planning.
  4. There is no cure or disease-changing medicine yet — but a great deal can be done. Physical and occupational therapy, braces (especially ankle-foot orthoses for foot drop), good foot care, exercise, and treatment of pain all genuinely help maintain function and quality of life.
  5. One safety point matters above all: avoid nerve-toxic medicines. Certain drugs — above all the chemotherapy drug vincristine — can cause severe, sometimes irreversible worsening of CMT and must be avoided. Always tell every doctor you have CMT.
  6. Common features include high-arched feet, hammertoes, foot drop, "stork-leg" thinning of the lower legs, balance problems, and reduced sensation in the feet and hands.
  7. The first medicine aimed at CMT1A is in late-stage trials. PXT3003, a combination treatment, showed benefit in a large phase 3 trial and is under regulatory review — a hopeful sign that disease-targeted treatment may be coming.
  8. Foot care and fall prevention are important. Because of weakness and reduced sensation, foot problems and falls are common but largely preventable with the right footwear, braces, home safety, and regular foot checks.
  9. It is inherited, and the pattern depends on the type. Many forms pass with a 50% chance to each child; CMTX has a special X-linked pattern. Genetic counseling helps families understand and plan.
  10. Care is best coordinated by a team familiar with CMT (neurology, physical/occupational therapy, orthotics, sometimes orthopedics), and organizations like the CMTA offer excellent support, including a list of medicines to use with caution.
▼ Collapse

Understanding Charcot-Marie-Tooth Disease

A diagnosis of Charcot-Marie-Tooth disease (CMT) often comes with a lot of questions, partly because the name is unfamiliar (it comes from the three doctors who first described it — it has nothing to do with teeth) and partly because it is a slowly progressive, lifelong condition. This guide explains what CMT is, how it's diagnosed, what helps, the crucial safety point about certain medicines, and the research bringing the first targeted treatments closer. The overall message is encouraging: CMT is not life-threatening, most people remain active and independent, and a great deal can be done to maintain function and quality of life.

CMT is a group of inherited disorders affecting the peripheral nerves — the nerves that carry signals between the spinal cord and the muscles and skin of the arms and legs. When these nerves don't work properly, the muscles they control gradually weaken and waste, and sensation (touch, temperature, position sense) is reduced. Because the longest nerves are affected first, symptoms usually begin in the feet and lower legs — foot deformities, foot drop, and balance problems — and later involve the hands. CMT is the most common inherited neurological condition, affecting roughly 1 in 2,500 people. It is not contagious, does not affect the brain or intelligence, and does not shorten life for the great majority of people.

Keeping perspective. CMT is usually slowly progressive — changes happen over years, not days — and it varies widely from person to person, even within a family. Many people lead full, active lives with the help of braces, therapy, and sensible adaptations. The purpose of this guide is practical: to help you understand the condition, protect your nerves (especially from harmful medicines), and access the support and devices that keep you mobile and independent.

The big picture

If there is one frame to hold onto, it is this: CMT is a manageable, non-life-threatening condition, and while there is no cure yet, a great deal can be done to keep you mobile, comfortable, and independent. The progression is usually slow, measured in years, which means there is time to adapt and plan rather than face sudden change. The most effective tools — physical and occupational therapy, ankle-foot braces, good footwear, foot care, exercise, and pain treatment — are practical and widely available, and they genuinely preserve function. One safety habit protects you more than any other: making sure every clinician knows you have CMT so that nerve-toxic medicines (above all vincristine) are avoided. And for the first time, a treatment aimed at the underlying disease (for the common CMT1A type) is in late-stage trials, offering real hope for the future. The rest of this guide walks through each piece — understanding your type, getting the right diagnosis, the supportive care that helps most, protecting your nerves, planning for family, and finding support — so you can act on all of them.

The main types

CMT is not a single disease but a family of related conditions, grouped by how they affect the nerves and by which gene is involved:

  • CMT1 — the “demyelinating” types, where the insulating sheath around nerves is affected. About half of all cases. The most common type of all, CMT1A, is caused by an extra copy (duplication) of the PMP22 gene.
  • CMT2 — the “axonal” types, where the nerve fiber itself is affected. Often somewhat milder, with less sensory loss.
  • CMTX — an X-linked type (caused by changes in the GJB1 gene), which has a distinctive inheritance pattern and often affects males more than females.
  • Other and rarer types — including recessive forms and many specific genetic subtypes.

Knowing your specific type can help predict the likely course, guide care, and inform family planning, which is why genetic testing is often worthwhile.

A few practical points about the types help put them in perspective. Even though there are many genetic subtypes, a small number account for most cases — CMT1A alone is the cause in roughly 4 of every 10 people with CMT — so genetic testing usually starts by looking for the common changes first. The type partly influences what to expect: the demyelinating types (CMT1) tend to begin earlier and the axonal types (CMT2) sometimes later and with less sensory loss, though there is wide overlap and the supportive care is broadly similar across types. The X-linked form (CMTX) matters especially for family planning because of its distinctive inheritance pattern. A handful of rarer subtypes have specific features (for example, occasionally affecting breathing, the voice, hearing, or the spine more), which is another reason identifying the exact type can be useful — it lets your team watch for anything specific to your subtype. For most people, though, the core message is the same regardless of type: maintain function with therapy and braces, protect your feet and your nerves, and stay connected to care.

Common questions, honest answers

  • “Will I end up in a wheelchair?” Most people with CMT keep walking, often with the help of braces and aids; a minority need a wheelchair for longer distances or later in life. The slow pace and the effectiveness of braces and therapy mean most people stay mobile for the long term.
  • “Is it fatal?” No. CMT affects the peripheral nerves that control movement and sensation; it does not affect the brain, and the great majority of people have a normal lifespan.
  • “Will it get much worse quickly?” CMT is usually slowly progressive over years. A sudden or rapid worsening is unusual and should prompt a check, because it may signal a separate, sometimes treatable, problem.
  • “Can exercise hurt me?” Sensible, moderate exercise is good for you and is encouraged; the only caution is to avoid exhausting overwork. A physical therapist can tailor a safe program.
  • “Will my children have it?” It depends on the type — many forms carry a 50% chance per child, while the X-linked form has a special pattern. Genetic counseling explains your situation.
  • “Is there a cure coming?” Not a cure yet, but the first treatment aimed at the most common type (CMT1A) is in late-stage trials and under review — the most hopeful the field has been.

What CMT is — and isn't

A few clarifications head off common worries. CMT is not contagious — you cannot catch it or give it to anyone except through inheritance. It is nobody's fault; it results from a genetic change, sometimes inherited and sometimes arising new. It does not affect intelligence or the brain — CMT is a condition of the peripheral nerves controlling movement and sensation, and thinking, memory, and personality are unaffected. It is not a muscle disease in the primary sense (though muscles weaken because their nerves are affected), and it is not the same as multiple sclerosis, ALS, or muscular dystrophy, which are different conditions with different outlooks. For most people it is not life-threatening and does not shorten life. And a diagnosis is not a prediction of severe disability: because CMT is so variable and slowly progressive, many people have a mild course, and supportive care keeps the great majority mobile and independent. Understanding what CMT is — and what it isn't — replaces a lot of unnecessary fear with a clear, manageable picture.

Questions to ask your doctor

  • What type of CMT do I have, if it's known?
  • What can I do now to maintain my strength, balance, and function?
  • Which medicines should I avoid, and how do I make sure other doctors know?
  • Should I see a physical therapist, occupational therapist, or orthotist?
  • Is genetic counseling appropriate for me and my family?

Diagnosis

CMT is diagnosed by recognizing its characteristic pattern, supported by nerve tests and confirmed by genetic testing. Getting a clear diagnosis — and ideally the specific type — guides care and family planning.

CMT in children

When CMT begins in childhood (as the common CMT1A type often does), the early signs can be subtle and easy to misread: a child who is clumsy, trips often, is “not sporty,” has trouble keeping up running, develops high-arched feet or curled toes, or wears out shoes unevenly. Some children have delayed motor milestones; others seem fine until later. Recognizing CMT in a child is valuable because it allows early support — physical therapy, the right footwear and braces, and monitoring of the feet and spine — that helps the child stay active and comfortable, and it informs the family. Importantly, children with CMT can and should stay physically active; sensible activity is good for them, and a physical therapist can suggest suitable sports and exercises. School staff may need to understand that fatigue and difficulty with certain physical tasks are real, not a lack of effort. If a child has these signs — especially with a family history of similar foot or walking problems — it's reasonable to ask about CMT and seek evaluation by a pediatric neurologist. Early, supportive care sets children up to do well.

Recognizing CMT

Common clues include slowly progressive weakness and changes starting in the feet (high arches, hammertoes, foot drop, frequent ankle sprains or tripping), thinning of the lower-leg muscles (sometimes described as “stork legs” or an “inverted champagne bottle” shape), reduced sensation in the feet, balance difficulties, and later weakness or clumsiness of the hands. Reduced or absent reflexes are common. A family history of similar foot problems or “weak ankles” is an important clue, though some people are the first in their family to be affected.

The family-history clue

Family history is one of the most useful pieces of the puzzle in CMT, because the condition is inherited — but it can be easy to miss. Relatives with CMT may never have been formally diagnosed, instead being known for “weak ankles,” “bad feet,” high arches, frequent ankle sprains, or a particular way of walking; an older relative's foot surgery or difficulty with stairs may, in hindsight, have been CMT. So when CMT is suspected, it's worth gently asking about these patterns across the family. That said, not everyone with CMT has a known family history: some people are the first in their family to be affected (a new gene change), and in the X-linked form, female relatives may have only mild or no symptoms while still carrying and passing on the gene. Bringing any family information you have to your appointment — and being open to the possibility even without a clear family history — helps your doctor recognize CMT and decide which genetic tests make sense. Once a diagnosis is made, it can also be valuable (and sometimes a relief) for relatives to understand their own situation.

The tests

  • Clinical examination — assessing the pattern of weakness, sensation, reflexes, and foot shape.
  • Nerve conduction studies / EMG — tests that measure how well the nerves carry signals, helping confirm a neuropathy and distinguish demyelinating (CMT1) from axonal (CMT2) types.
  • Genetic testing — the definitive test, identifying the specific gene change (such as the PMP22 duplication of CMT1A). It confirms the diagnosis, identifies the type, and enables accurate family counseling.
Why pinning down the type helps. Identifying the specific genetic type can clarify what to expect, occasionally has type-specific implications, and is essential for family planning and for matching to clinical trials (some treatments in development target specific types, such as CMT1A). It also confirms the diagnosis definitively, avoiding uncertainty. A genetic counselor or neuromuscular specialist can guide which tests make sense.

Treatable conditions that can mimic CMT

One important reason to get a clear, confirmed diagnosis is that a few other nerve conditions can resemble CMT — and some of those are treatable, so it matters not to assume every slowly progressive neuropathy is CMT. Two examples stand out. CIDP (an inflammatory nerve condition) can look like the demyelinating form of CMT but responds to immune treatments; clues that point to CIDP rather than CMT include a faster or more uneven course or particular nerve-test findings. Hereditary ATTR amyloidosis is an inherited condition that can slowly mimic the axonal type of CMT, and — importantly — it now has effective approved treatments (such as tafamidis, patisiran, vutrisiran, and eplontersen), so recognizing it changes everything. Because these treatable look-alikes can be subtle, this is another reason that genetic testing and evaluation by a neuromuscular specialist are worthwhile, especially if there's no clear family history of CMT, if the course is unusual, or if there are features (like heart or autonomic symptoms) that aren't typical of CMT. Getting the precise diagnosis ensures you receive treatment for a treatable condition if that's what you have.

Questions to ask your doctor

  • Has my diagnosis been confirmed, and is my specific type known?
  • Would genetic testing add useful information for me or my family?
  • What does my type suggest about the likely course?
  • Who should coordinate my ongoing care?

Treatment & Management

There is no medicine yet that cures or slows CMT, but — importantly — that does not mean nothing can be done. A great deal of effective, practical care maintains function, comfort, mobility, and independence, and protecting the nerves from harm is a key part of the plan.

The shape of CMT care. Think of management as having three parts: maintaining function (therapy, exercise, braces, devices), preventing problems (foot care, fall prevention, and avoiding nerve-toxic medicines), and treating symptoms (pain, foot deformities). Done well, this keeps people mobile and active for the long term — and disease-targeted medicines are now on the horizon.

Why supportive care is so effective

It's easy to hear “there's no cure” and feel that little can be done — but the opposite is true, and understanding why helps you make the most of care. In CMT, much of the day-to-day difficulty comes not only from the nerve changes themselves but from their downstream effects: foot drop that causes tripping, foot deformities that make walking painful or shoes uncomfortable, weakened balance that risks falls, and the deconditioning that creeps in when activity drops. These downstream effects are exactly what supportive care targets — and they respond well. A good ankle-foot brace can transform an unstable, tiring gait into a confident one; physical therapy maintains the strength and balance you have and slows the deconditioning spiral; foot care and the right footwear prevent painful wounds and deformity progression; and treating pain keeps you active. None of this changes the underlying genetics, but all of it changes how well you function and feel day to day — which is what quality of life is built from. So while research works toward disease-changing medicines, the supportive tools available right now genuinely and measurably improve life with CMT. They are worth pursuing fully, not as a fallback, but as the core of effective care today.

Therapy, exercise, and devices

Physical therapy helps maintain strength, flexibility, and balance, and reduces the risk of falls; occupational therapy helps with hand function and daily tasks. Moderate exercise — such as walking, swimming, or cycling, plus balance work — is encouraged and beneficial (the aim is to stay fit and maintain function, not to exhaust muscles). Ankle-foot orthoses (AFOs) — braces that support the foot and ankle — are one of the most valuable tools for foot drop, improving walking and stability; other devices, special footwear, and orthotics help too. As needs change, mobility aids and home adaptations support independence.

A little more on braces, because they are so central. Ankle-foot orthoses (AFOs) come in different styles — from lightweight, flexible carbon-fiber designs to more supportive rigid ones — and a good orthotist matches the brace to your needs, helping with foot drop, stability, and walking efficiency, often dramatically. Many people are initially reluctant to use braces, seeing them as a sign of decline, but most who try well-fitted AFOs find they walk more confidently, trip less, and tire less — in other words, braces enable activity rather than limit it. It can take a little time to get the fit and style right, so it's worth persisting and giving feedback to your orthotist. Beyond AFOs, supportive footwear, custom insoles for high-arched feet, and sometimes other devices (canes, walking poles) all help. As your needs change over the years, your braces and aids can be updated. Pairing the right orthotics with ongoing physical therapy is one of the most effective things you can do to stay mobile.

Foot care and surgery

Because CMT affects the feet so commonly — high arches, hammertoes, and reduced sensation — good foot care matters: well-fitting protective footwear, daily checks for sores or injuries (which may not be felt), and prompt attention to any wounds. When foot deformities cause significant pain or difficulty walking despite braces and orthotics, orthopedic foot surgery can sometimes correct the alignment and improve function; this is considered individually with an orthopedic specialist familiar with CMT.

On foot surgery specifically: it is not needed by everyone, and braces and orthotics are always tried first — but for some people, the foot deformities of CMT (a fixed high arch, clawed toes, an ankle that rolls) become painful or make walking and bracing difficult, and surgery can genuinely help. Operations range from soft-tissue procedures (releasing or rebalancing tendons) to bone procedures that realign the foot, sometimes combined. The goals are a more stable, better-aligned, pain-free foot that fits comfortably in shoes and braces. Timing and the choice of procedure matter and should be planned with an orthopedic surgeon experienced in CMT, because the underlying muscle imbalance needs to be taken into account so the correction lasts. Recovery takes time and rehabilitation, but for well-selected people the improvement in comfort and walking can be substantial. If foot problems are limiting you despite good braces and footwear, it's reasonable to ask for a referral to discuss whether surgery could help.

Pain and other symptoms

Many people with CMT experience pain — musculoskeletal pain from altered mechanics and posture, and sometimes neuropathic (nerve) pain — and it is very treatable with a combination of therapy, footwear/braces, and medicines where appropriate. Muscle cramps, fatigue, and cold-sensitive hands and feet are common and can be managed. The key message is that symptoms should not simply be endured — tell your team, because most can be eased.

Because pain is common and sometimes under-discussed in CMT, it is worth a closer look. Two kinds tend to occur. Musculoskeletal pain — in the feet, ankles, knees, hips, and back — arises from the altered shape and mechanics of the feet and from changes in how you walk and stand; it often responds well to the right braces and footwear, physical therapy, posture and gait work, and sometimes standard pain relievers. Neuropathic pain — burning, tingling, or shooting sensations from the affected nerves — is less universal but, when present, can be treated with medicines specifically for nerve pain. Muscle cramps, especially at night, are also common and can be eased with stretching, hydration, and sometimes medication. The important message is that you should not simply put up with pain: tell your care team, because a tailored combination of physical measures and, where needed, medicine usually brings meaningful relief. Managing pain well also helps you stay active, which in turn helps maintain function — so it's worth addressing rather than enduring.

⚠ Avoid nerve-toxic medicines — especially vincristine. Some drugs can damage peripheral nerves and cause severe, sometimes irreversible worsening of CMT. The most important is the chemotherapy drug vincristine, which can cause rapid, serious deterioration — even after only one or two doses, and even in people whose CMT was mild or not yet diagnosed — and must be avoided in CMT. Other drugs (including certain other chemotherapies and some other medicines) should be used with caution. Always tell every doctor, including oncologists and surgeons, that you have CMT, and ask whether any prescribed medicine could affect the nerves. The CMTA maintains a helpful list of medicines to avoid or use cautiously.

Questions to ask your doctor

  • Would braces (AFOs), therapy, or other devices help me?
  • How should I care for my feet and prevent falls?
  • Is any of my pain treatable, and how?
  • Which medicines must I avoid, and is this noted in my records?

Living Long-Term, Pregnancy & Trials

This section covers living with more advanced CMT, special situations, and the research bringing the first targeted treatments closer.

Living well as CMT progresses

CMT usually progresses slowly, and the focus over time is on maintaining mobility, independence, and quality of life. Priorities include keeping up with therapy and exercise to preserve strength and balance; updating braces and mobility aids as needs change; fall prevention (home safety, lighting, removing trip hazards); managing pain and fatigue; and protecting the hands (occupational therapy and adaptive tools help with buttons, writing, and fine tasks). Most people maintain good function with these supports; for the minority with more significant disability, a wider range of aids and home adaptations keeps daily life manageable. Fatigue is common and real — pacing and energy conservation help.

When CMT affects the hands

Although CMT usually starts in the feet, over time it can affect the hands — causing weakness of grip and of the small muscles, reduced fine-motor control, and sometimes reduced sensation — which can make tasks like buttoning, writing, opening jars, or using a keyboard harder. This is a common and understandable worry, but there is a lot that helps. Occupational therapy is key: a therapist can teach techniques and recommend simple adaptive tools (built-up grips, button hooks, jar openers, easier fasteners, voice-to-text for typing) that preserve independence in daily tasks and at work. Hand exercises and splints can help maintain function and comfort in some cases. Protecting the hands also matters — reduced sensation means being careful with heat and sharp objects. As with the feet, the message is that hand involvement is manageable with the right strategies and tools, and addressing it early — before it becomes limiting — preserves the most function. If you notice changes in your hands, raise it with your team so support can be put in place.

Understanding the course and outlook

People naturally want to know what to expect, and the honest answer is that CMT is highly variable — which argues against grim predictions and in favor of focusing on what you can do. In general, CMT progresses slowly over many years; most people remain walking and independent, using braces and aids as needed, and continue to work and pursue their lives. Some types (and some individuals) are milder, with little progression; others are more significant. Severity loosely relates to the type and to how early symptoms began, but these are not precise predictors for any one person, and even relatives with the same gene change can be affected quite differently. Importantly, CMT does not affect the brain or shorten life for the great majority, and the supportive treatments genuinely change the trajectory of function — braces, therapy, and foot care keep people mobile who might otherwise struggle. The most constructive approach is to stay active and engaged, keep up with therapy and the right equipment, protect your nerves from harmful drugs, and stay connected to expert care and the research community — because, with disease-targeted treatments now in trials, the outlook is genuinely improving.

Mobility aids and independence

As CMT progresses, mobility aids can be a positive tool rather than a setback — the goal is always to keep you doing what matters to you. Beyond ankle-foot braces, options that help at different stages include walking poles or a cane for balance and confidence, especially on uneven ground; a wheelchair or scooter for longer distances (which many people use selectively — for a day at a museum or airport — while walking normally otherwise, conserving energy for what they enjoy); and home and vehicle adaptations (handrails, ramps, hand controls) that maintain independence. Occupational therapists and physical therapists can recommend the right aids at the right time and ensure they fit your life. Many people find that using an aid increases what they can do — less fatigue, fewer falls, more confidence — rather than limiting them. There is no “giving in” in using a tool that helps; the measure of success is staying active, safe, and engaged in your life, by whatever means work best for you.

Pregnancy and family planning

CMT is inherited, so family planning is an important consideration. The chance of passing it on depends on the type: many forms are passed with a 50% chance to each child, while CMTX has a distinctive X-linked pattern (which affects the odds and severity differently for sons and daughters) — a genetic counselor can explain your specific situation and options, including prenatal testing and preimplantation genetic testing. During pregnancy, some women with CMT notice a temporary worsening of symptoms, and CMT can affect aspects of labor and delivery, so pregnancy is best managed by a team aware of the condition; most women with CMT have healthy pregnancies. As always, certain medicines (including some used around childbirth and anesthesia) warrant the usual CMT caution — ensure the team knows your diagnosis.

>Clinical trials and research

For decades CMT had no disease-targeted treatment, but that is beginning to change:

  • PXT3003 — a combination medicine (low doses of baclofen, naltrexone, and sorbitol) aimed at CMT1A — has been studied in large phase 3 trials (PLEO-CMT, NCT02579759, and the more recent PREMIER trial, NCT04762758), with reported improvements in measures of neuropathy and function, and is under regulatory review. It could become the first treatment specifically for CMT1A.
  • Gene-targeted approaches — including therapies designed to lower the overactive PMP22 gene in CMT1A — are in earlier development and represent a promising future direction.
  • Research also continues into treatments for other CMT types and into better braces, devices, and symptom management.
Considering a trial? Clinical trials can offer access to investigational treatments and expert assessment, but involve uncertainty and may include a placebo. The CMTA and neuromuscular centers are good resources for finding trials and patient registries (joining a registry can help match you to studies). Ask what is being tested, the risks and benefits, and what participation involves, and discuss any trial with your neurologist.

Questions to ask your doctor

  • What can we do to keep me mobile and independent over the long term?
  • If I'm planning a pregnancy, how should we prepare?
  • Are there clinical trials relevant to my type of CMT, and should I join a registry?

Support & Resources

Below are guidance on living well, support organizations, a glossary, what does not work, and the sources behind this guide.

Living well with CMT

Beyond medical care, several things help daily life. Stay active and engaged — appropriate exercise and therapy maintain function and mood. Invest in the right footwear and braces, which make a bigger difference to walking and confidence than people often expect, and look after your feet with regular checks. Build a care team familiar with CMT, and keep a simple record of your diagnosis and the medicines you must avoid to share with any new clinician. Address the emotional side: living with a progressive condition can be stressful, and counseling and peer support genuinely help. And connect with the CMT community — organizations offer education, practical tips, and a sense of not being alone, which many people find invaluable.

Practical day-to-day strategies

Small, consistent habits make a real difference with CMT. For walking and balance, use your braces and well-fitting, supportive footwear consistently — they prevent trips and conserve energy — and keep up the therapy exercises that maintain strength and stability. For your feet, check them daily for any redness, blisters, or sores (because reduced sensation means you might not feel an injury), keep nails and skin cared for, and treat any wound promptly. For hands and fine tasks, occupational therapy can suggest tools and techniques (built-up grips, button hooks, voice typing) that preserve independence. For energy, pace demanding activities and build in rest; fatigue is a real part of CMT, not laziness. For safety at home, good lighting, clear floors, grab bars, and handrails reduce falls. And carry a simple medical summary — your diagnosis and the medicines you must avoid (especially vincristine) — so any clinician, including in an emergency, knows to protect your nerves. None of these are complicated, but together they keep you mobile, safe, and independent.

For family and caregivers

Family and caregivers can help in valuable ways. Understand that CMT's fatigue and the effort of walking are real and often invisible — planning around energy levels, rather than pushing through, helps everyone. Help keep the practical supports in place: attending appointments, keeping braces and footwear in good repair, and watching for foot injuries the person may not feel. Be a second set of eyes for the medication safety point — making sure every new doctor, dentist, or hospital knows about the CMT diagnosis and the need to avoid nerve-toxic drugs. Support independence rather than taking over: the goal is to enable the person to do as much as they safely can. And because CMT is inherited, relatives may have their own questions about testing and risk, which genetic counseling can address for the whole family. Caregivers should also look after themselves and tap into the CMT community for shared experience and practical tips.

Why joining a registry or community helps

One simple, low-effort step that can make a real difference is connecting with a patient registry and the CMT community. A registry is a secure database of people with CMT who agree to share some health information for research; joining can connect you to clinical trials you might be eligible for (researchers use registries to find participants — important now that the first disease-targeted treatments are being tested), and it ensures your experience contributes to understanding the condition and speeding new treatments. Beyond research, organizations like the CMTA and Hereditary Neuropathy Foundation offer something just as valuable: practical, lived-experience knowledge — tips on braces and footwear, navigating work and benefits, the all-important list of medicines to avoid, and the reassurance of connecting with others who understand. For a relatively common but still under-recognized condition, this kind of organized community has helped drive research investment and is part of why the treatment pipeline has grown. Even if you're not currently interested in a trial, being connected keeps the door open and strengthens the collective effort — and many people find the community itself makes living with CMT noticeably easier.

Mountain West / Utah

  • University of Utah Health — Neuromuscular/Neurology program (Salt Lake City), with EMG/nerve-conduction testing, genetics, physical/occupational therapy, and orthotics; appointments via University of Utah Health (801-585-7575).
  • Intermountain Health — neurology, rehabilitation, and orthotics services across the region.
  • Shriners Children's (Salt Lake City) — orthopedic and orthotic care for children with CMT (including foot/limb issues).
  • George E. Wahlen VA Medical Center (Salt Lake City) — neurology and rehabilitation for eligible veterans.

National organizations

  • Charcot-Marie-Tooth Association (CMTA) (cmtausa.org) — the leading CMT organization: education, a Centers of Excellence network, a list of medicines to avoid/use with caution, support, and research/trial information.
  • Hereditary Neuropathy Foundation (HNF) (hnf-cure.org) — patient support, education, and research.
  • Muscular Dystrophy Association (MDA) (mda.org; 1-833-275-6321) — care centers and resources for neuromuscular conditions including CMT.
  • NINDS (ninds.nih.gov) and ClinicalTrials.gov — for research and trial information.

Getting good care wherever you are

CMT care is mostly about access to the right supportive services rather than a single specialist, and there are ways to get good care wherever you live. A neuromuscular clinic or CMTA Center of Excellence can confirm the diagnosis and type and set up a clear plan, which local clinicians and therapists then help deliver; telehealth is increasingly available for follow-up. The most valuable services to access are physical and occupational therapy and a good orthotist for braces — these do the heavy lifting in maintaining function. Crucially, the one thing every clinician you see must know — even those far from CMT expertise — is that you have CMT and that nerve-toxic medicines must be avoided; keep this on a card and in your records. National organizations like the CMTA and Hereditary Neuropathy Foundation can help you find experienced clinicians, navigate insurance and access to braces and devices, and connect with the CMT community and trials. Because research interest in CMT is growing, awareness and access to knowledgeable care are gradually improving.

International access

CMT is recognized worldwide, and the foundation of care — diagnosis, therapy, braces and orthotics, foot care, and avoidance of nerve-toxic medicines — is achievable wherever neurology and rehabilitation services exist; the supportive, multidisciplinary model is broadly similar across countries. Access to genetic testing, specialized neuromuscular clinics, and advanced orthotics varies by region. The investigational CMT1A treatment PXT3003 is under regulatory review in some regions but is not yet broadly approved. The universal priorities are the same everywhere: confirm the diagnosis (and ideally the type), maintain function with therapy and orthoses, protect the feet, and — critically — ensure every clinician knows to avoid vincristine and other nerve-toxic drugs.

The emotional side

CMT is not only physical — living with a slowly progressive, visible condition can carry a real emotional weight that deserves acknowledgment. It is common to feel frustration at changing abilities, worry about the future, self-consciousness about braces or an altered gait, or sadness about activities that have become harder. These feelings are normal and are not a sign of weakness or of “not coping.” Several things help: connecting with others who have CMT (through the CMTA, Hereditary Neuropathy Foundation, or online communities) so you don't feel alone; counseling or therapy if low mood or anxiety becomes persistent; focusing on what you can do and adapting how you do other things rather than giving them up; and being open with family and friends about what helps. Many people find that the practical steps in this guide — getting the right braces, staying active, protecting their nerves — also restore a sense of control that improves mood. If the emotional side becomes hard, tell your care team; psychological support is a legitimate and valuable part of CMT care, not separate from it.

What does not work

Being clear about limits helps. There is currently no medicine approved to cure or slow CMT (the first targeted treatment, PXT3003 for CMT1A, remains investigational/under review). Earlier trials of high-dose vitamin C for CMT1A, once hoped to help, did not show benefit in large studies and are not recommended. No supplement or alternative therapy has been shown to treat CMT, and some (including high-dose vitamin B6) can themselves harm nerves, so tell your team about anything you take. And it bears repeating that certain prescription medicines — above all vincristine — can seriously worsen CMT and must be avoided. The genuinely effective “treatments” today are the supportive ones: therapy, braces, foot care, exercise, and pain management.

  • Charcot-Marie-Tooth disease (CMT): a group of inherited disorders of the peripheral nerves causing weakness and sensory loss.
  • Peripheral nerves: the nerves connecting the spinal cord to the muscles and skin of the limbs.
  • Demyelinating (CMT1) vs axonal (CMT2): two ways the nerves are affected — the insulating sheath versus the nerve fiber itself.
  • CMT1A: the most common type, caused by a duplication of the PMP22 gene.
  • CMTX: an X-linked type caused by GJB1 gene changes.
  • Foot drop: difficulty lifting the front of the foot, causing tripping; helped by ankle-foot braces.
  • Pes cavus: a high-arched foot, common in CMT.
  • Ankle-foot orthosis (AFO): a brace that supports the foot and ankle.
  • Vincristine: a chemotherapy drug that can severely worsen CMT and must be avoided.
  • PXT3003: an investigational combination treatment for CMT1A.

A hopeful, realistic close

Living with CMT means holding two truths together. It is a lifelong, slowly progressive condition with no cure yet — that is real. But it is also a condition where most people stay active and independent, where the supportive treatments (braces, therapy, foot care, exercise, pain management) genuinely preserve function and quality of life, and where, for the first time, a disease-targeted treatment is in late-stage trials. The people who do best are those who stay engaged: using the right braces and footwear, keeping up with therapy and sensible exercise, looking after their feet, protecting their nerves by avoiding harmful medicines, planning ahead for family questions, and staying connected to knowledgeable care and a supportive community. CMT may change how you do some things, but it rarely needs to stop you from living a full, meaningful life. Use this guide as a practical companion, lean on your care team and on organizations like the CMTA and Hereditary Neuropathy Foundation, and take encouragement from a research field that is, after many years, finally moving toward treatments aimed at the disease itself.

Key sources

Based on standard neurology and neuromuscular references on CMT classification (CMT1/CMT2/CMTX and the PMP22, MPZ, MFN2, and GJB1 genes), diagnosis (nerve conduction studies and genetic testing), and supportive management (therapy, orthoses, foot care, pain, and avoidance of neurotoxic drugs such as vincristine); the Charcot-Marie-Tooth Association guidance on medicines to avoid; and the CMT1A treatment trials of PXT3003 (PLEO-CMT, NCT02579759; PREMIER, NCT04762758), plus ClinicalTrials.gov registry data. This guide is educational and is not a substitute for advice from your own medical team.

Financial Considerations

Currently, there are no FDA-approved disease-modifying drugs specifically for Charcot-Marie-Tooth disease (CMT). The main financial challenges relate to supportive care costs, orthotic devices, genetic testing, and physical/occupational therapy. This is changing as the CMT treatment pipeline advances.

Orthotic devices and bracing

Physical and occupational therapy

Genetic testing

Disability and financial support

Clinical trials as access to emerging therapies

Several promising CMT therapies are in active clinical trials. Participation in a clinical trial may provide access to investigational drugs at no cost to the patient, along with close clinical monitoring and transportation/travel reimbursement at many centers. Search ClinicalTrials.gov for "Charcot-Marie-Tooth" to see current studies, and ask your neurologist or the CMT Association about trials you may qualify for.

⚠️ Safety Warnings & Critical Drug Risks

Neurotoxic Drugs — Can Cause Severe Irreversible Deterioration in CMT

INFORM ALL PRESCRIBERS AND PHARMACISTS of your CMT diagnosis before any new medication. The following drugs can cause sudden, severe, or permanent worsening of CMT neuropathy:

  • Vincristine (chemotherapy): absolutely contraindicated in CMT1A and most CMT subtypes — multiple documented cases of severe paralysis and death; alternatives exist for most cancers requiring vincristine; wear a CMT medical alert bracelet
  • Taxanes (paclitaxel/Taxol, docetaxel/Taxotere): high risk of severe permanent neuropathy worsening; discuss CMT diagnosis with oncologist before any chemotherapy; alternatives are often available
  • Amiodarone (antiarrhythmic): causes peripheral neuropathy; avoid in CMT; many alternatives exist
  • Thalidomide / lenalidomide: significant neurotoxicity risk; discuss with treating physician before prescribing for any indication
  • Nitrofurantoin (common UTI antibiotic): can worsen neuropathy; request alternatives (trimethoprim, fosfomycin)
  • Metronidazole (Flagyl): risk with prolonged or high-dose use; prefer short courses and alternatives when available
  • Bortezomib: significant neuropathy risk in CMT; always discuss CMT diagnosis with oncologist

Physical Safety & Injury Prevention

  • Medical alert bracelet recommended listing "CMT — avoid vincristine, taxanes, amiodarone, thalidomide" for emergency situations and anesthesia consultations
  • Ankle and foot injuries may be more severe and heal more poorly due to sensory loss and foot deformity; use prescribed ankle-foot orthoses (AFOs); report new falls, sudden weakness, or ankle pain promptly
  • Heat sensitivity: symptoms may temporarily worsen in heat — not disease progression; take precautions and pace activity
  • Isoniazid (TB antibiotic): always co-prescribe pyridoxine (vitamin B6) to reduce peripheral neuropathy risk; inform prescribing physician of CMT diagnosis